REPRAT 40MG GASTRO RESISTANT TABLET

Страна: Кипр

Язык: греческий

Источник: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Активный ингредиент:

PANTOPRAZOLE SODIUM SESQUIHYDRATE

Доступна с:

DELORBIS PHARMACEUTICALS LTD (0000009620) 17 ATHINON STREET, ERGATES INDUSTRIAL AREA, LEFKOSIA, 2081, 28629

код АТС:

A02BC02

ИНН (Международная Имя):

PANTOPRAZOLE

дозировка:

40MG

Фармацевтическая форма:

GASTRO RESISTANT TABLET

состав:

PANTOPRAZOLE SODIUM SESQUIHYDRATE (8000001653) 45,15MG

Администрация маршрут:

ORAL USE

Тип рецепта:

Εθνική Διαδικασία

Терапевтические области:

PANTOPRAZOLE

Обзор продуктов:

Νομικό καθεστώς: Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 20 TABS IN BLISTER(S) (300010404) 20 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 30 TABS IN BLISTER(S) (300010405) 30 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται

тонкая брошюра

REPRAT 40 - COMPARATIVE TABLE PIL-EN VS PIL-GR
Package leaflet: Information for the user
Reprat 40 mg gastro-resistant tablets
pantoprazole
Read all of this leaflet carefully before you start taking this
medicine because it contains important information for you.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, pharmacist or
nurse.
-
This medicine has been prescribed for you only. Do not pass it on
to others. It may harm them, even if their signs of illness are the
same as yours.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in this leaflet.
See
section 4.
What is in this leaflet:
1. What Reprat is and what it is used for
2. What you need to know before you take Reprat
3. How to take Reprat
4. Possible side effects
Φύλλο οδηγιών χρήσης: Πληροφορίες για
τον χρήστη
Reprat 40 mg γαστροανθεκτικά δισκία
παντοπραζόλη
Διαβάστε προσεκτικά ολόκληρο το φύλλο
οδηγιών χρήσης πριν αρχίσετε
να παίρνετε αυτό το φάρμακο, διότι
περιλαμβάνει σημαντικές πληροφορίες
για σας.
-
Φυλάξτε αυτό το φύλλο οδηγιών χρήσης.
Ίσως χρειαστεί να το διαβάσετε
ξανά.
-
Εάν έχετε περαιτέρω απορίες, ρωτήστε
τον γιατρό, τον φαρμακοποιό ή τον
νοσοκόμο σας.
-
Η συνταγή για αυτό το φάρμακο
χορηγήθηκε αποκλειστικά για σας. Δεν
πρέπει να δώσετε το φάρμακο σε άλλους.
Μπορεί να τους προκαλέσει
βλάβη, ακόμα και όταν τα συμπτώματα
της ασθένειάς τους είναι ίδια με τα
δικά σας.
-
Εάν παρατηρήσετε κάποια ανεπιθύ

Характеристики продукта

1.
NAME OF THE MEDICINAL PRODUCT
Reprat 40 mg Gastro-resistant tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 40 mg pantoprazole as pantoprazole sodium
sesquihydrate.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Gastro-resistant tablets
Reprat 40 mg tablets are oval, yellow coloured gastro-resistant coated
tablets.
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Reprat is indicated for use in adults and adolescents 12 years of age
and above for:
-
Reflux oesophagitis.
Reprat is indicated in adults for:
-
Eradication of Helicobacter pylori (H. pylori) in combination with
appropriate antibiotic
therapy in patients with H. pylori associated ulcers.
-
Gastric and duodenal ulcer.
-
Zollinger-Ellison-Syndrome and other pathological hypersecretory
conditions.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults and adolescents 12 years of age and above
Reflux oesophagitis
1
SUMMARY OF PRODUCT CHARACTERISTICS
One tablet of Reprat per day. In individual cases the dose may be
doubled (increase to 2 tablets
Reprat daily) especially when there has been no response to other
treatment. A 4-week period is
usually required for the treatment of reflux oesophagitis. If this is
not sufficient, healing will
usually be achieved within a further 4 weeks.
Adults
Eradication of H. pylori in combination with two appropriate
antibiotics
In H. pylori positive patients with gastric and duodenal ulcers,
eradication of the germ by a
combination therapy should be achieved. Considerations should be given
to official local
guidance (e.g. national recommendations) regarding bacterial
resistance and the appropriate use
and prescription of antibacterial agents. Depending upon the
resistance pattern, the following
combinations can be recommended for the eradication of H. pylori:
a) Twice daily one tablet Reprat
+ twice daily 1000 mg amoxicillin
+ twice daily 500 mg clarithromycin
b) Twice daily one tablet Reprat
+ twice daily 400 - 500 mg metronidazole (or 500 mg tinidazole)
+ twice dail